Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • claudin 18.2 targeted therapy

Tag: claudin 18.2 targeted therapy

AstraZeneca stomach cancer drug trial graphic of two competing claudin 18.2 conjugates
  • Pharmaceuticals

AstraZeneca Stomach Cancer Drug Trial: Sone-Ve Versus the Rival Claudin 18.2 ADC

Megan Wood11 hours ago11 hours ago010 mins

How the AstraZeneca stomach cancer drug trial compares with Takeda’s rival claudin 18.2 ADC, plus regulatory status and corrected numbers.

Read More

Categories

  • Healthcare IT (21)
  • Industry Insights (319)
  • Lifestyle and Wellness (24)
  • Medical Devices (34)
  • Pharmaceuticals (73)
  • Uncategorized (1)

Recent Posts

  • AstraZeneca Stomach Cancer Drug Trial: Sone-Ve Versus the Rival Claudin 18.2 ADC
  • Takeda Gastric Cancer Drug Trial: Filing Plans, Partner and Pipeline Impact
  • Roche Divarasib Phase 3 Trial: What It Means for Lumakras and Krazati
  • Paras Healthcare IPO Subscription: What Investors Are Buying in the Hospital Group
  • Talkiatry Therapy Services Nationwide: What Patients Should Know
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.